期刊文献+

小剂量伊布利特辅助的持续性心房颤动导管消融治疗 被引量:5

Low-dose ibutilide facilitated catheter ablation for persistent atrial fibrillation
原文传递
导出
摘要 目的:报道小剂量伊布利特辅助下进行持续性心房颤动(房颤)导管消融治疗的初步结果。方法前瞻性入选2011年11月至2013年4月连续102例在首都医科大学附属北京朝阳医院心内科接受导管消融治疗的持续性房颤患者,其中男68例,女34例,平均年龄(62±11)岁。首先行环肺静脉电隔离术( CPVI),然后静脉给予0.25 mg的伊布利特,观察30 min。如房颤转复为窦性心律( SR)则不予进一步的心房基质改良;如房颤转为房性心动过速( AT)则仅消融AT;如仍为房颤,则行心房碎裂电位( CFAE )消融,直至 SR 恢复或 CFAE 已被消除或 CFAE 消融时间已达30 min。结果41例(40.2%)患者经CPVI±小剂量伊布利特后房颤被终止(SR或者AT)为组1。其余61例(59.8%)患者进一步接受了平均时间为(14.0±5.6) min 的CFAE消融,其中25例(41.0%)患者房颤被终止为组2;36例患者经电复律恢复SR为组3。平均随访(501±224) d,单次消融成功率为69.6%(71例)。组1和组2的成功率(分别为82.9%和76.0%)显著高于组3(50.0%,P值均〈0.01)。结论小剂量伊布利特辅助的持续性房颤导管消融术疗效可以接受,并在实时评估房颤维持基质及减少无效CFAE消融等方面具有潜在优势。 Objective To report the efficacy of low-dose ibutilide facilitated catheter ablation for per-sistent atrial fibrillation(PsAF). Methods One hundred and two consecutive patients [68 men,34 women, mean age of(62±11)years] who underwent index catheter ablation for PsAF were enrolled from November 2011 to April 2013 in this prospective study. After circumferential pulmonary vein isolation ( CPVI ) , low-dose (0. 25 mg) ibutilide was administered over 3 min in patients without PsAF termination. In case of PsAF was terminated,either converted to sinus rhythm( SR) or transformed to atrial tachycardia( AT) by ibutilide within 30 minutes,no further ablation targeting complex fractionated atrial electrogram( CFAE) was performed. In con-trast, CFAE ablation was performed until SR restored or all CFAE was eliminated or CFAE ablation time achieved 30 minutes. Results In 41(40. 2%) patients,PsAF was terminated by CPVI±ibutilide(Group 1). Further CFAE ablation was performed in another 61(59. 8%) patients,in whom PsAF was terminated by CFAE ablation in 25 patients(Group 2) or by external cardioversion in 36 patients(Group 3). The mean CFAE abla-tion time was(14. 0±5. 6) min. After a mean follow-up of(501±224) d,the success rate after the index ablation procedure was 69. 6%(71 patients). The success rate of Group 1 and Group 2 was 82. 9% and 76. 0%,respec-tively. Both were significantly higher than that in Group 3(50%,P〈0. 01 for both). Conclusion The efficacy of low-dose ibutilide facilitated catheter ablation for PsAF is acceptable,with potential strengths in on-line eval-uating the atrial maintenance substrate and reducing ineffective CFAE ablation.
出处 《中华心律失常学杂志》 2014年第2期83-88,共6页 Chinese Journal of Cardiac Arrhythmias
基金 国家自然科学基金(81100125,81370293,81070146) 科技部国际合作项目(S20112R0197) 首都卫生发展科研专项项目(重点攻关,首发2011-2003-4)
关键词 心血管病学 心房颤动 导管消融 抗心律失常药物 Cardiology Atrial fibrillation Catheter ablation Anti-arrhythmic drug
  • 相关文献

参考文献9

  • 1黄从新,张澍,马长生,刘旭,杨延宗,曹克将,马坚,吴书林,刘少稳,江洪,鲁端,徐亚伟,黄德嘉,陈新.中国经导管消融治疗心房颤动注册研究-2008[J].中华心律失常学杂志,2011,15(4):247-251. 被引量:18
  • 2Jadidi AS, Duncan E, Miyazaki S, et al. Functional nature of elec- trogram fractionation demonstrated by left atrial high-density map- ping [ J ]. Circ Arrhythm Electrophysio1,2012,5 : 32-42.
  • 3Oral H, Souza JJ, Michaud GF, et al. Facilitating transthoracic car- dioversion of atrial fibrillation with ibutilide pretreatment [ J 1. N Engl J Med, 1999,340 : 1849-1854.
  • 4Nademanee K, McKenzie J, Kosar E, A new approach for catheter ablation of atrial fibrillation : mapping of the electrophysiologic sub- strate [ J 1. J Am Coil Cardio1,2004,43:2044-2053.
  • 5Matsuo S, Lellouche N, Wright M, et al. Clinical predictors of ter- mination and clinical outcome of catheter ablation for persistent at- rial fibrillation [ J ]. J Am Coil Cardiol, 2009,54:788-795.
  • 6Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atri- al fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, end- points, and research trial design: a report of the Heart Rhythm Soci- ety(HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association(EHRA) ,a registered branch of the European Society of Cardiology(ESC) and the European Cardiac Arrhythmia Society (ECAS) ;and in collaboration with the American College of Cardiology( ACC ), American Heart Association ( AHA ) , the Asia Pacific Heart Rhythm Society( APHRS), and the Society of Tho- racic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the Europe- an Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society [ J 1. Heart Rhythm,2012,9:632-696. e21.
  • 7Nademanee K, McKenzie J, Kosar E, et al. A new approach for catheter ablation of atrial fibrillation : mapping of the electrophysio- logic substrate[ J]. J Am Coil Cardiol,2004,43:2044-2053.
  • 8Chou CC,Zhou S,Tan AY, et al. High-density mapping of pulmo- nary veins and left atrium during ibutilide administration in a ca- nine model of sustained atrial fibrillation [ J ]. Am J Physiol Heart Cire Physio1,2005,289 : H2704-2713.
  • 9Singh SM, D' Avila A, Kim S J, et al. Intraprocedural use of ibutil- ide to organize and guide ablation of complex fractionated atrial electrograms: preliminary assessment of a modified step-wise ap- proach to ablation of persistent atrial fibrillation [ J ]. J Cardiovasc Electrophysiol,2010 ,21:608-616.

二级参考文献5

共引文献17

同被引文献38

  • 1Panagiotis Korantzopoulos,Konstantinos P Letsas,Anna Kotsia,Giannis Baltogiannis,Kallirroi Kalantzi,Konstantinos Kyrlas,John A Goudevenos.Ibutilide and novel indexes of ventricular repolarization in persistent atrial fibrillation patients[J].World Journal of Cardiology,2013,5(7):242-246. 被引量:3
  • 2侯霄雷,赵雷,朱亮,严理,王重卿,华金福,李白翎.联合应用伊布利特与普罗帕酮转复持续性心房颤动的临床研究[J].临床内科杂志,2007,24(11):768-770. 被引量:1
  • 3January CT,Wann LS,Alpert JS,et al.2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:a re- port of the American College of Cardiology/American Heart Associa- tion Task Force on Practice Guidelines and the Heart Rhythm Society[J].J Am Coll Cardiol,2014,64(21):2305-2307.
  • 4Oral H,Pappone C,Chugh A,et al.Circumferential pulmonary- vein ablation for chronic atrial fibrillation[J].N Engl J Med,2006,354(9):934-941.
  • 5Haissaguerre M,Jais P,Shah DC,et al.Spontaneous initiation of at- rial fibrillation by ectopic beats originating in the pulmonary veins[J].N Engl J Med,1998,9(10):659-666.
  • 6Ouyang F,Emst S,Chun J,et al.Electrophysiological findings dur- ing ablation of persistent atrial fibrillation with electroanatomic map- ping and double Lasso catheter technique[J].Circulation,2005,112(20):3038-3048.
  • 7Kettering K,Weig HJ,Busch M,et al.Catheter ablation of persis- tent atrial fibrillation:anatomically based circumferential pulmonary vein ablation in combination with a potential-guided segmental ap- proach to achieve complete pulmonary vein isolation[J].J Interv Card Electrophysiol,2011,30(1):63-72.
  • 8Calkins H,Brugada J,Packer DL,et al.HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibril- lation:recommendations for personnel,policy,procedures and fol- low-Up.A report of the Heart Rhythm Society (HRS)task force on catheter and surgical ablation of atrial fibrillation[J].Europace,2007,9(6):335-379.
  • 9Lim TW,Jassal IS,Ross DL,et al.Medium-term efficacy of segmen- tal ostial pulmonary vein isolation for the treatment of permanent and persistent atrial fibrillation[J].Pacing Clin Electrophysiol,2006,29(4):374-379.
  • 10Katritsis D,Wood MA,Giazitzoglou E,et al.Long-term follow-up after radiofrequency catheter ablation for atrial fibrillation[J].Europace,2008,10(4):419-424.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部